Loyola University Chicago Health Sciences Campus
OFFICE OF RESEARCH SERVICES SPECIAL SEMINAR and DISCUSSION
Chicago LEARN: An Opportunity for Collaboration in Hospital-based Patient-Centered Outcomes Research in Chicago
Initial funding for the development of LEARN was obtained from a competitive supplement to the University of Chicago CTSA from the National Center for Research Resources (2011-2012). Additional funding to date includes renewal funding of the University of Chicago CTSA (2012-2017) and a Centers for Medicare and Medicaid Innovation (CMMI) Innovation Challenge Award (2012-2015) to study the effects of increased continuity in the doctor-patient relationship on costs and outcomes for frequently hospitalized patients. With funding from AHRQ, Chicago LEARN centers are also collaborating to complete a study of the effectiveness of pharmacogenetic vs. clinically guided warfarin dosing among hospitalized patients.
Chicago LEARN Participants:
Chicago LEARN: An Opportunity for Collaboration in Hospital-based Patient-Centered Outcomes Research in Chicago
- by David Meltzer, MD, PhD Chief, Section of Hospital Medicine Director, Center for Health and the Social Sciences The University of Chicago
- Monday, September 24, 2012 9:00 - 10:00 p.m. SSOM, Room 460
- Dr. Meltzer and Dr. Julian Solway will be available after the presentation to discuss Chicago LEARN and the University of Chicago CTSA.
- For additional information, please contact: Richard H. Kennedy, Ph.D. Vice Provost, Research and Graduate Programs
Initial funding for the development of LEARN was obtained from a competitive supplement to the University of Chicago CTSA from the National Center for Research Resources (2011-2012). Additional funding to date includes renewal funding of the University of Chicago CTSA (2012-2017) and a Centers for Medicare and Medicaid Innovation (CMMI) Innovation Challenge Award (2012-2015) to study the effects of increased continuity in the doctor-patient relationship on costs and outcomes for frequently hospitalized patients. With funding from AHRQ, Chicago LEARN centers are also collaborating to complete a study of the effectiveness of pharmacogenetic vs. clinically guided warfarin dosing among hospitalized patients.
Chicago LEARN Participants:
- The University of Chicago CTSA: (The University of Chicago, Rush University Medical Center, Northshore University Healthsystem, Mercy Hospital)
- The Northwestern University CTSA
- The University of Illinois at Chicago CTSA
- UHC (formerly University Healthsystem Consortium)
- Loyola University Chicago and Loyola University Medical Center (in Development)
- John H. Stroger Hospital of Cook County (in Development)
- Jesse Brown and Edward Hines Veterans Administration Hospitals (in Development)